Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fetal gene reactivation

R A Swank1, G Stamatoyannopoulos

  • 1Division of Medical Genetics, University of Washington, Seattle 98195-7720, USA. raswank@u.washington.edu

Current Opinion in Genetics & Development
|August 5, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Population structure of modern-day Italians reveals patterns of ancient and archaic ancestries in Southern Europe.

Science advances·2019
Same author

De novo mutations producing unstable hemoglobins or hemoglobins M : I. Establishment of a Depository and use of data to test for an association of de novo mutation with advanced parental age.

Human genetics·2016
Same author

Evidence for the in vivo safety of insulated foamy viral vectors.

Gene therapy·2016
Same author

Prospects for developing a molecular cure for thalassemia.

Hematology (Amsterdam, Netherlands)·2005
Same author

Predominant expression of human Agamma--in contrast with beta-globin gene in MEL cells transfected with the construct muLCRAgamma psibeta deltabeta.

Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih·2003
Same author

Quantification of DNaseI-sensitivity by real-time PCR: quantitative analysis of DNaseI-hypersensitivity of the mouse beta-globin LCR.

Journal of molecular biology·2001

Reactivating silent fetal genes offers a novel treatment for genetic disorders. Activating fetal hemoglobin synthesis in adults shows promise for treating beta chain hemoglobinopathies.

Area of Science:

  • Genetics and Molecular Biology
  • Hematology
  • Developmental Biology

Background:

  • Genetic diseases often stem from mutations in adult-expressed genes.
  • Reactivating fetal or embryonic genes presents a therapeutic strategy.
  • Fetal hemoglobin induction in adults is a model for treating beta chain hemoglobinopathies.

Purpose of the Study:

  • To review the molecular control of the beta globin locus.
  • To explore the cellular and molecular basis of fetal hemoglobin induction in adults.
  • To summarize approaches for stimulating fetal hemoglobin synthesis in patients.

Main Methods:

  • Literature review of molecular genetics and hematology.
  • Analysis of cellular mechanisms for gene reactivation.

Related Experiment Videos

  • Synthesis of current therapeutic strategies for hemoglobinopathies.

    • Main Results:

    • Understanding of beta globin locus regulation is advancing.
    • Cellular and molecular pathways for fetal hemoglobin induction are being elucidated.
    • Various methods are being investigated to stimulate fetal hemoglobin production.

    Conclusions:

    • Reactivating silent fetal genes is a viable therapeutic approach for genetic diseases.
    • Targeting fetal hemoglobin synthesis offers a potential treatment for beta chain hemoglobinopathies.
    • Further research into molecular control and induction methods is crucial for clinical application.